Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $19.5100 (-2.45%) ($19.3100 - $20.1700) on Thu. Aug. 22, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.83% (three month average) | RSI | 22 | Latest Price | $19.5100(-2.45%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.5% a day on average for past five trading days. | Weekly Trend | IOVA declines -5.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) XBI(48%) ARKG(47%) IWO(44%) ARKK(42%) | Factors Impacting IOVA price | IOVA will decline at least -1.915% in a week (0% probabilities). VIXM(-28%) VXX(-15%) UUP(-9%) IFRA(-6%) TLT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.915% (StdDev 3.83%) | Hourly BBV | 0 () | Intraday Trend | -2.5% | | | |
|
1 - 5 Day Possible Target | $4.72(-75.81%) | Resistance Level | $22.05 | 5 Day Moving Average | $20.03(-2.6%) | 10 Day Moving Average | $20.57(-5.15%) | 20 Day Moving Average | $22.05(-11.52%) | To recent high | -25% | To recent low | 19.3% | Market Cap | $2.857b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |